Investigating Microparticle Levels In Filtered Packed Red Blood Cell Units
NCT06428747 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2024-05-24
Summary
Red blood cell (RBC) transfusion is a common therapeutic approach, and almost 85 million packed red blood cells (pRBCs) are transfused annually worldwide.Transfusion efficacy largely depends on the patient's general health, but the composition of transfused pRBCs also can have an impact.
Conditions
- Packed Red Cells Causing Adverse Effects in Therapeutic Use
Interventions
- DIAGNOSTIC_TEST
-
b. Detection of micro particles and their subtypes by flow cytometery on(BECKMAN COULTER CytoFLEX flow cytometer).
detection of micro-particles
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-04-01
- Primary Completion
- 2025-03-30
- Completion
- 2025-04-30
Countries
- Egypt
Study Locations
More Related Trials
-
Study of Safe Blood Transfusion Volumes to Correct Acute Severe Anaemia
NCT01461590 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Spectra Optia Red Blood Cell Exchange in Sickle Cell Patients
NCT01736657 ·Status: COMPLETED ·Phase: NA
-
Hydoxycarbamide and L-Carnitine Therapy in Sickle Cell Anemia
NCT05081349 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)
NCT00982007 ·Status: COMPLETED ·Phase: PHASE3
-
Full Assessment of Clinical Transfusion Support
NCT07094646 ·Status: COMPLETED
-
PICU Transfusion Study: Harmful Effects of Red Blood Cell Transfusions
NCT02087553 ·Status: COMPLETED
-
Study the Effect of Blood Transfusion on Oxidant-antioxidant Status in Term and Near-term Neonates
NCT03767361 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
RBC Transfusion in Severe Anemia With Lactic Acidosis
NCT01586923 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous Ferric Carboxymaltose vs IV Iron Sucrose or IV Iron Dextran in Treating Iron Deficiency Anemia in Women
NCT01290315 ·Status: COMPLETED ·Phase: PHASE2
-
The Implementation of the Automated Erythrocytapheresis in Egyptian Sickle Cell Disease Center
NCT03903289 ·Status: RECRUITING ·Phase: NA
-
Role of Hematological Parameters in the Stratification of COVID-19 Disease Severity
NCT04670328 ·Status: COMPLETED
-
Iron Depletion and Replacement in Blood Donors
NCT01752413 ·Status: COMPLETED ·Phase: NA
-
A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera
NCT05210790 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients
NCT00548860 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Beet Juice for Patients With Sickle Cell Anemia
NCT02162225 ·Status: WITHDRAWN ·Phase: PHASE2
-
Sucrosomial Iron and Iron Sulphate to Blood Donors
NCT05678647 ·Status: COMPLETED ·Phase: NA
-
Impact of the Preparation Method of Red Cell Concentrates on Transfusion Indices in Thalassemic Patients
NCT03992001 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding
NCT00395993 ·Status: COMPLETED ·Phase: PHASE3
-
Hypophosphatemia With Ferric Carboxymaltose Vs. Iron Dextran in Iron Deficiency Secondary to Heavy Uterine Bleeding
NCT01307007 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Acquired Hemolytic Anemia in Adult Hospitalized Patients
NCT06708728 ·Status: NOT_YET_RECRUITING
-
Effects of the Contraceptive Implant in Women With Sickle Cell Disease
NCT05730205 ·Status: RECRUITING ·Phase: PHASE4
-
HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity
NCT02435901 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)
NCT06985147 ·Status: RECRUITING ·Phase: PHASE2
-
Biotin-Acridine Red Cell Exchange Kinetics
NCT07155031 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron Overload
NCT01039636 ·Status: COMPLETED ·Phase: PHASE1